English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Aug 2, 2026

KAIST team develops RNA-based therapy to address cancer-associated cachexia

+ Pharmaceuticals
Patient Daily | Aug 2, 2026

Traditional Japanese medicine studied for potential to reduce age-related tissue fibrosis

+ Pharmaceuticals
Patient Daily | Aug 2, 2026

Researchers identify immune cell changes linked to long COVID in new study

+ Pharmaceuticals
Patient Daily | Aug 2, 2026

Study links persistent financial adversity to poorer midlife cognitive performance and brain health

+ Pharmaceuticals
Patient Daily | Jul 31, 2026

Review discusses strategies to reduce recurrent hepatic encephalopathy and related hospitalizations

+ Pharmaceuticals
Patient Daily | Jul 31, 2026

Review suggests lower protein intake may improve health and extend lifespan

+ Pharmaceuticals
Patient Daily | Jul 31, 2026

Novo Nordisk’s IL-6 inhibitor fails to reduce cardiovascular events in Phase 3 study

+ Pharmaceuticals
Patient Daily | Jul 31, 2026

Study finds sperm cooperation may boost fertilization in arthropods

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily